短暂
发表于 2025-3-21 18:02:29
书目名称Viral Hepatitis: Chronic Hepatitis C影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0983202<br><br> <br><br>书目名称Viral Hepatitis: Chronic Hepatitis C读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0983202<br><br> <br><br>
助记
发表于 2025-3-21 20:49:37
Laboratory and Molecular Diagnosis of Hepatitis C and Resistance Testing,stics as well. Here in this chapter, we elaborate the techniques used in the laboratory and molecular testing for the hepatitis C virus along with the resistance testing. The chapter focuses on the screening and confirmatory tests that are used in the diagnosis of HCV along with the indications for
推延
发表于 2025-3-22 02:35:01
http://reply.papertrans.cn/99/9833/983202/983202_3.png
注意
发表于 2025-3-22 05:51:00
http://reply.papertrans.cn/99/9833/983202/983202_4.png
脆弱吧
发表于 2025-3-22 12:21:40
Treatment of Hepatitis C Virus-Infected Patients with Renal Failure,HCV infection is independently associated with the development of chronic kidney disease. The selection of the most appropriate regimen depends on genotype, presence or absence of cirrhosis, prior treatment history, and, in patients with renal failure, degree of renal impairment. Since HCV infection
Leaven
发表于 2025-3-22 16:50:31
Treatment of Hepatitis C Virus in Special Populations (HBV Coinfection, Drug Users, and Prisoners),d in geographical areas where both infections have an intermediate or a high endemicity level and in special populations at high risk of acquiring both infections. Patients with dual-HBV/HCV infection more frequently develop liver cirrhosis and hepatocellular carcinoma (HCC) than those with a single
细丝
发表于 2025-3-22 19:19:59
HIV/HCV Coinfection: Current Challenges,.It was previously observed that HIV/HCV-coinfected patients suffered from faster progression of liver fibrosis compared to HCV-mono-infected patients, resulting in increased rates of cirrhosis and decompensation of liver disease. However, over the past decade, the natural history of HIV/HCV coinfec
UTTER
发表于 2025-3-23 00:53:46
Management of Interferon-Free Direct-Acting HCV Antiviral Therapy Failure,rhosis, liver failure, and hepatocellular carcinoma if remains untreated. The landscape of chronic hepatitis C treatment has evolved rapidly since 2011 with the arrivals of multiple combinations of direct-acting antiviral (DAA) therapies with the excellent sustained virological response, in the 90%.
被诅咒的人
发表于 2025-3-23 03:05:47
http://reply.papertrans.cn/99/9833/983202/983202_9.png
博识
发表于 2025-3-23 08:26:09
Extrahepatic Manifestations of Hepatitis C Virus Infection, because of the additional HCV-associated extrahepatic manifestations (EHMs) that occur. HCV infection is a global health problem, with 150–170 million people being chronically infected. It is estimated that about 350,000 patients die from HCV-related complications. However, the risks of mortality a